Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

UCN-01 Enhances the In Vitro Toxicity of Clinical Agents in Human Tumor Cell Lines

1 May 2000

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer-related Molecular Pathways
Share to Cancer therapeutics and mechanisms
Share to DNA Repair Mechanisms

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 10857990
DOI: 10.1023/a:1006313611677

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 11 closest

UCN-01 Enhances the In Vitro Toxicity of Clinical Agents in Human Tumor Cell LinesPMID 10857990Read ↗

Efficacy of anti-cancer agents in cell lines versus human primary tumour tissueSemantic proximity Read ↗

Rationale and clinical use of multitargeting anticancer agentsSemantic proximity Read ↗

Molecular pharmacology and antitumor activity of Zalypsis® in several human cancer cell linesSemantic proximity Read ↗

Challenges in pre-clinical testing of anti-cancer drugs in cell culture and in animal modelsSemantic proximity Read ↗

Characterizations of irofulven cytotoxicity in combination with cisplatin and oxaliplatin in human colon, breast, and ovarian cancer cellsSemantic proximity Read ↗

UCN-01 selectively enhances mitomycin C cytotoxicity in p53 defective cells which is mediated through S and/or G2 checkpoint abrogationSemantic proximity Read ↗

A phase II study of UCN-01 in combination with irinotecan in patients with metastatic triple negative breast cancer.Semantic proximity Read ↗

Preclinical Development of the Novel Chk1 Inhibitor SCH900776 in Combination with DNA-Damaging Agents and AntimetabolitesSemantic proximity Read ↗

A novel indolocarbazole, ICP-1, abrogates DNA damage-induced cell cycle arrest and enhances cytotoxicity: similarities and differences to the cell cycle checkpoint abrogator UCN-01.Semantic proximity Read ↗

The apoptotic effect of cordycepin on human OEC-M1 oral cancer cell lineSemantic proximity Read ↗

Toxicological impact of JWH-018 and its phase I metabolite N-(3-hydroxypentyl) on human cell linesSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.